Coronavirus Vaccine is effective in preventing admission of patients in hospital and emergency department due to delta variant of SARS-CoV-2 virus. Research using national data also indicates that the Moderna vaccine is significantly more effective against delta variants than the Pfizer and Johnson & Johnson vaccines. It is worth noting that the Delta variant is spreading rapidly around the world.
Sean Granis, vice president of data and analytics at the Regenstrife Institute in the US, and study author, said real-world data suggests that the vaccine is more effective in reducing hospital and emergency department admissions for Covid-associated cases. Even the vaccine is effective against the variant of Kovid-19. In a statement, Granis said, we ask all those who are eligible to get the vaccination. Through this, serious disease caused by corona can be avoided and the pressure on the health care system of the country can be reduced.
More likely to be hospitalized if not vaccinated
The authors noted that the VISION Network of the Centers for Disease Control and Prevention (CDC) analyzed more than 32,000 medical cases from nine states during June, July and August 2021. During this, the Delta variant was the reason for the corona cases coming up in America. He said that the results show that people who are not vaccinated against Kovid-19 are 5 to 7 times more likely to be hospitalized. The same is also against different variants of corona, due to which vaccination is very important.
This information came out about the effectiveness of vaccines
This study has been published in the Morbidity and Mortality Weekly Report, which is published by the CDC. Through this, the difference in the effectiveness of mRNA vaccines is also revealed. The authors said the Moderna vaccine was up to 95 percent effective in preventing hospitalization in people 18 years of age and older over the study period. He said, the Pfizer vaccine is 80 percent effective, while Johnson & Johnson is up to 60 percent effective in preventing hospitalization among people 18 years of age and older. The study also found that the vaccine is slightly less effective for people aged 75 years and older.
read this also: